Molecular scissoring technique involves the use of restriction enzymes commonly called molecular scissors. These enzymes cut the DNA near or at specific recognition sequences called restriction sites. One incision is made on each of the two strands of the DNA. The cleaved DNA can be transferred to vectors, which can then infect host cells. Vectors do this by hijacking the host cell machinery to reproduce. With this, molecular scissors find direct or indirect applications in molecular biology as tools for gene editing, mapping, and sequencing. Molecular scissoring technology further finds applications in the study of prevention and treatment of various diseases in plants, animals, and humans.
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the molecular scissoring technology market.
Top Impacting Factors
DNA mapping involves the use of molecular scissors to obtain structural information about the genetic material. In addition, mapping involves determining the order of the restriction enzyme site in the genome. Rise in number of studies done with the intent of DNA mapping in different countries is one of the factors that propel the growth of the molecular scissors market.
Many R&D activities are focused on the field of molecular cloning, restriction landmark genomic scanning, gene sequencing, and serial analysis of gene expression (SAGE), which could further propels the growth of the molecular scissors technology market.
In addition, molecular scissor helps in the production of personalized medicine, also known as precision medicine. It involves processes meant to help in the detection, prevention, and treatment of a disease in a patient using information from the patient's genetic makeup. Hence, this can act as a key growth factor of the growth.
However, with stringent policies, rules, and regulations that revolve around the use of molecular scissors, it is difficult to see the growth of the market at a high rate. In addition, molecular scissoring techniques are costly, which restrains the molecular scissoring technology market growth.
Key Market Trends
Recently, scientists in Israel have developed molecular scissoring software that helps cut DNA microscopically. This software takes readings from the existing machines and eliminates 99% of false cuts changes to improve efficacy while performing molecular scissoring.
There have been unique developments in CRISPR-Cas9. Cas9 can edit parts of the genome by altering and adding sections of the DNA. It is currently the most versatile and simplest method of genetic manipulation. In addition, Cas9 is the cheapest, fastest, and most reliable system for editing genes.
Drug developments such as that of PF-07321332 BY Pfizer, Inc. have been done following the principle behind molecular scissoring. This drug by Pfizer, Inc. was designed to act against the SARS-CoV-2 virus. The drug was designed to fit into the enzyme called protease, which cuts long protein chains. Proteases cut proteins into smaller pieces, which are then used as part of viral replication in the patient’s body. By fitting in proteases, the drug could block the scissoring action of the enzyme. If the drug is proven to be safe, it could be used widely.
Key Benefits of the Report
- This study presents the analytical depiction of the molecular scissoring technology industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the molecular scissoring technology market share.
- The current market is quantitatively analyzed to highlight the growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the molecular scissoring technology market .
- The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.
Questions Answered in the Molecular Scissoring Technology Market Report
- Which are the leading players active in the molecular scissoring technology market?
- How is each segment of the market expected to grow during the forecast period?
- What are the adoption trends for the molecular scissoring technology market in emerging economies and established economies across the world?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps?
- What are the impacts of COVID-19 in the industry?
- What is molecular scissoring technology?
- What is the molecular scissoring technology market prediction in the future?
- What are the current trends and predicted trends?
Molecular Scissoring Technology Market Report Highlights
| Aspects | Details |
 By Type |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Editas Medicine, Intellia Therapeutics, Inc., Sangamo Therapeutics, Recombinetics, Caribou Biosciences, Inc., Cellectis, Cibus, Inc., Thermo Fisher Scientific, Inc., Merck, Precision BioSciences |
Loading Table Of Content...
